Epidermal Growth Factor Receptor Exon 19 Deletions Predict Complete Regression of Multiple Intracranial Metastases in Two Cases of Non-small Cell Lung Cancer Treated with Erlotinib

被引:9
作者
Benedetti, Giovanni [1 ]
Latini, Luciano [2 ]
Galletta, Domenico [2 ]
Collucci, Giuseppe [1 ]
Crino, Lucio [3 ]
机构
[1] Hosp Macerata, Dept Med Oncol, Macerata, Italy
[2] Oncol Inst BARI, Dept Med Oncol, Bari, Italy
[3] Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy
关键词
MUTATIONS; DOMAIN;
D O I
10.1097/JTO.0b013e3181a9a0a2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:936 / 937
页数:2
相关论文
共 5 条
[1]   Response of intracranial metastases to erlotinib therapy [J].
Fekrazad, M. Houman ;
Ravindranathan, Meera ;
Jones, Dennie V., Jr. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) :5024-5026
[2]   Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: An analytical database [J].
Murray, Samuel ;
Dahabreh, Issa J. ;
Linardou, Helena ;
Manoloukos, Menelaos ;
Bafaloukos, Dimitrios ;
Kosmidis, Paris .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) :832-839
[3]  
Paz-Ares L, 2006, J CLIN ONCOL, V24, p369S
[4]   Chemotherapy for brain metastases of lung cancer: A review [J].
Postmus, PE ;
Smit, EF .
ANNALS OF ONCOLOGY, 1999, 10 (07) :753-759
[5]  
Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585